The LBT solution is an innovative new procedure for the treatment of Acute Myocardial Infarction. Our proprietary, non-invasive treatment uses a special wearable probe that utilizes an external laser to activate the bone marrow to release immunomodulatory factors into the circulatory system. These factors (proteins and different cells) hone in to the MI scar and significantly reduce post MI scarring.


Studies on LBT's technology have shown positive initial results in minimizing scarring, post Acute Myocardial Infarction, in Gastroenterology Conditions as well as in Neurological disorders, such as Alzheimer's Disease.


LLLT has been shown to have a photobiostimulatory effect on stem cells. LBT completed the in-vivo stage and have shown that applying LLLT to bone marrow in pigs, rats and mice post-myocardial infarction results in a reduction of scar tissue formation in the heart.


Our goal is to integrate this cutting edge cell therapy activation via LLLT, into clinical products and treatments that extend and improve the quality of life of individuals suffering from acute and chronic diseases.